Clinical Trial

Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the use of Next Generation Sequencing (NGS) to detect circulating tumor DNA in gastric cancer patients after gastrectomy
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-08-25; most recent amendment 2025-08-08.
Status change: Recruiting → Active, Not Recruiting 2025-08-08
Status change: Not Yet Recruiting → Recruiting 2021-11-08
Trial Details
NCT Number NCT05029869
Lead Sponsor University Medical Center Ho Chi Minh City (UMC)
Conditions Gastric Cancer, ctDNA
Enrollment 100 participants
Start Date 2021-10-04
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-13